VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $45,410,000 | +21943.7% | 1,953,930 | +14975.5% | 0.01% | – |
| Q1 2018 | $206,000 | -99.1% | 12,961 | -98.8% | 0.00% | -100.0% |
| Q4 2017 | $22,466,000 | +21094.3% | 1,081,135 | +14078.8% | 0.01% | – |
| Q3 2017 | $106,000 | +16.5% | 7,625 | +45.5% | 0.00% | – |
| Q2 2017 | $91,000 | +71.7% | 5,239 | +8.6% | 0.00% | – |
| Q1 2017 | $53,000 | +12.8% | 4,826 | +52.1% | 0.00% | – |
| Q4 2016 | $47,000 | -99.3% | 3,172 | -98.9% | 0.00% | -100.0% |
| Q3 2016 | $6,878,000 | -55.2% | 280,123 | -63.3% | 0.00% | -50.0% |
| Q2 2016 | $15,366,000 | -33.9% | 762,998 | -13.7% | 0.00% | -33.3% |
| Q1 2016 | $23,254,000 | -97.1% | 884,184 | -88.7% | 0.01% | -97.0% |
| Q4 2015 | $792,118,000 | -50.3% | 7,792,599 | -12.8% | 0.20% | -53.3% |
| Q3 2015 | $1,594,378,000 | +15.6% | 8,938,107 | +44.0% | 0.43% | +31.1% |
| Q2 2015 | $1,378,815,000 | +13.0% | 6,206,671 | +1.0% | 0.32% | +16.9% |
| Q1 2015 | $1,220,607,000 | +36.4% | 6,145,437 | -1.8% | 0.28% | +35.6% |
| Q4 2014 | $895,159,000 | +10.0% | 6,255,040 | +0.8% | 0.20% | +6.2% |
| Q3 2014 | $814,092,000 | +3.4% | 6,204,964 | -0.6% | 0.19% | -3.5% |
| Q2 2014 | $787,591,000 | -17.6% | 6,244,783 | -13.9% | 0.20% | -24.2% |
| Q1 2014 | $955,915,000 | +9.4% | 7,251,120 | -2.6% | 0.26% | +6.5% |
| Q4 2013 | $873,959,000 | +19.2% | 7,444,286 | +5.9% | 0.25% | +14.3% |
| Q3 2013 | $733,147,000 | +76.9% | 7,027,173 | +45.9% | 0.22% | +64.4% |
| Q2 2013 | $414,511,000 | – | 4,815,450 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |